| |
|
|
|
NovaBay Pharmaceuticals Inc.  
|
|
1.25 -0.01 (-0.01%) |
12-14 15:43 |
|
Open: |
1.26 |
Pre close: |
1.26 |
Target:
|
1.65
|
|
High: |
1.26 |
Low: |
1.2 |
Resistance:
|
1.41
1.65
|
|
Volume: |
6,782 |
Market Cap: |
21M |
Support:
|
1.02
0.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.23
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.20 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
1.60  |
Stochastic Oscillator |
%K(14,3):
|
29.89 |
|
MA(250): |
2.51 |
%D(3): |
27.96 |
|
Average Volume(K) |
3-Month: |
2107
|
52-Week |
High:
|
4.20 |
|
10-Days: |
2965 |
Low: |
0.97 |
|
RSI |
RSI(14):
|
50.98 |
Change(%): |
-62.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.380 |
Return on Equity (ttm) |
-113.7 |
Shares Out. (M) |
17.09 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-41.9 |
Shares Float (M) |
15.31 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.40 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-23.2 |
% Held by Institutions |
1.70 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
52 |
|
Book Value (p.s.) |
3.530 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.29 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.35 |
|
Profit Margin |
-29.64 |
Operating Cash Flow
(M) |
-6.50 |
P/S |
23220108.00 |
|
Operating Margin |
-38.61 |
Levered Free Cash Flow
(M) |
-5.29 |
P/CF |
-3.29 |
|
|
|
|
|
|
